Mefenamic acid
CAS No. 61-68-7
Mefenamic acid( C.I. 473 | NSC 94437 )
Catalog No. M15330 CAS No. 61-68-7
Mefenamic acid is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of mefenamic acid is as a Cyclooxygenase Inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
200MG | 28 | In Stock |
|
500MG | 46 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMefenamic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionMefenamic acid is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of mefenamic acid is as a Cyclooxygenase Inhibitor.
-
DescriptionMefenamic acid is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of mefenamic acid is as a Cyclooxygenase Inhibitor. The chemical classification of mefenamic acid is Nonsteroidal Anti-inflammatory Compounds.(In Vitro):Mefenamic acid is a non-steroidal anti-inflammatory agent, acting as a competitive inhibitor of hCOX-1, with IC50s of 40 nM and 3 μM for hCOX-1 and hCOX-2, respectively. Mefenamic acid (0-100 μM) has cytotoxic effects on KB, Saos-2, and 1321N cells, however, U-87MG cells are resistant to Mefenamic acid.
-
In VitroMefenamic acid is a non-steroidal anti-inflammatory agent, acting as a competitive inhibitor of hCOX-1, with IC50s of 40 nM and 3 μM for hCOX-1 and hCOX-2, respectively. Mefenamic acid (0-100 μM) has cytotoxic effects on KB, Saos-2, and 1321N cells, however, U-87MG cells are resistant to Mefenamic acid.
-
In Vivo——
-
SynonymsC.I. 473 | NSC 94437
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-1| COX-2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number61-68-7
-
Formula Weight241.29
-
Molecular FormulaC15H15NO2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 48 mg/mL (198.93 mM)
-
SMILESc1(c(cccc1)C(=O)O)Nc1c(c(ccc1)C)C
-
Chemical Name2-(2,3-dimethylanilino)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bhat AS, et al. Eur J Pharmacol. 2007 Feb 5; 556(1-3):190-9.
molnova catalog
related products
-
Bufexamac
Bufexamac is a COX inhibitor for IFN-α release.
-
Indometacin
Indomethacin is a non-steroidal antiinflammatory agent (NSAIA) with antiinflammatory, analgesic and antipyretic activity.
-
Sodium salicylate
Sodium salicylate is a metabolite of acetylsalicylic acid, and functions by inhibiting NF-kB and reduces oxidative stress.